Zai Lab (ZLAB) Interest Expenses (2016 - 2026)
Zai Lab (ZLAB) posted Interest Expenses of $1.6 million for Q1 2026, down 92.31% sequentially from $21.3 million in Q4 2025, and up 37.91% YoY from $1.2 million in Q1 2025.
Zai Lab (ZLAB) Interest Expenses (2016 - 2026) Analysis & Trends
Zai Lab has reported Interest Expenses for 11 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Interest Expenses rose 37.91% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.6 million (up 629.24% YoY) and the FY2025 annual result came in at $429.2 million, up 8.71% from the prior year.
- Interest Expenses declined to $1.6 million in Q1 2026 per ZLAB's latest filing, from $21.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $284.1 million in Q4 2022 and troughed at $113000.0 in Q1 2024.
- A 5-year average of $29.3 million and a median of $1.3 million in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses plunged 96.72% in 2023, then jumped 1862.21% in 2025.
- Over 5 years, Interest Expenses stood at $284.1 million in 2022, then slumped by 96.72% to $9.3 million in 2023, then tumbled by 88.35% to $1.1 million in 2024, then surged by 1862.21% to $21.3 million in 2025, then sank by 92.31% to $1.6 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $1.6 million, $21.3 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 21.29 Mn |
| Dec 31, 2025 | 21.29 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 745,000.00 |
| Sep 30, 2024 | 745,000.00 |
| Jun 30, 2024 | 492,000.00 |
| Jun 30, 2024 | 492,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Mar 31, 2024 | 113,000.00 |